CPT® Code 90663

Deleted

The CPT® Code 90663 refers to the influenza virus vaccine specifically formulated for the pandemic strain of H1N1, commonly known as swine flu. H1N1 is classified as a subtype of influenza Type A, which is one of the two primary types of influenza viruses, the other being Type B. Vaccines are designed to target specific subtypes of the influenza virus to ensure effectiveness. The pandemic formulation of the H1N1 vaccine may differ from the interpandemic strains, incorporating unique additives, known as adjuvants, that enhance the immune response by increasing the antigen content. These formulations may also vary in dosage to optimize their efficacy during a pandemic situation. An influenza pandemic occurs when a novel strain of the virus emerges and spreads rapidly among the human population, often resulting in a significant lack of pre-existing immunity. This can lead to widespread severe illness and increased mortality rates. The administration of the pandemic formulation of the H1N1 influenza vaccine can be performed through a separately reportable intramuscular injection or intranasal route. It is essential to use this code in conjunction with the appropriate administration code to accurately identify the vaccine product for billing and documentation purposes.